查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1298837

按药物类别、适应症（胃食管反流病或烧心、便秘、腹泻、晕动症及其他）、终端用户和地区分類的胃肠道OTC药物市场2023-2028年

Gastrointestinal OTC Drugs Market by Drug Class, Indication (Gastroesophageal Reflux Disease or Heartburn, Constipation, Diarrhea, Motion Sickness, and Others), End User, and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

2022年，全球胃肠道非处方药市场规模达到400亿美元。展望未来，IMARC集团预计，到2028年，市场规模将达到524亿美元，在2023-2028年期间表现出4.90%的增长率（CAGR）。胃肠道疾病的发病率不断上升，大众对消化系统健康的认识不断提高，以及最近先进配方的开发代表了推动市场的一些关键因素。

胃肠道非处方药（OTC）是指缓解胃肠道症状和促进整体消化系统健康的非处方药。它包括泻药、抗酸剂、H2阻断剂、质子泵抑制剂（PPI）、止吐剂、肠道消炎剂和止泻药。胃肠道非处方药被广泛用于治疗消化不良、便秘、烧心、腹泻、晕车、反酸、恶心、肠易激综合征（IBS）和腹痛。它是一种具有成本效益的、方便的、容易获得的产品，能够提供即时的缓解，提高病人的舒适度，并允许自我管理。胃肠道OTC药物还有助于改善肠道健康，恢复有益细菌，预防未来的并发症，并最大限度地减少各种症状的严重性，如疼痛、腹胀、腹部不适和呕吐。

胃肠道非处方药市场趋势：

由于久坐的生活方式和不健康的饮食习惯，胃肠道疾病的发病率不断上升，这是推动市场增长的关键因素之一。胃肠道非处方药被广泛用于治疗感染、消化不良、急性腹泻、烧心、胃食管反流病（GERD）、便秘、腹胀和晨吐。此外，由于大众对消化健康的认识不断提高，越来越多的产品应用于改善消化，促进肠道健康，并确保营养物质的适当分解和吸收，这为市场增长提供了动力。与此相呼应，新兴的自我保健和消费者授权管理健康和预防未来健康并发症的趋势正在成为另一个增长诱导因素。此外，最近开发的先进配方，如泡腾片、液体、悬浮液、薄膜条和咀嚼产品，提高了药物的有效性，增加了吸收，减少了用药频率，正在对市场增长产生积极影响。除此之外，方便和便于旅行的包装，如吸塑包装、可重复密封的小袋和单剂量包装的推出，正在推动市场增长。除此之外，消费者对非侵入性治疗的偏好上升，促进了对管理常见消化问题和提供即时救济的产品需求。此外，一些制造商通过电视（TV）广告、社交媒体、影响者营销和名人代言进行的积极宣传和品牌推广活动正在加强市场增长。其他因素，包括老年人口的增加，消费者支出能力的提高，以及电子商务平台上产品的容易获得，预计将推动市场的增长。

本报告中回答的关键问题：

  • 迄今为止，全球胃肠道非处方药市场表现如何，未来几年将如何表现？
  • 全球胃肠道非处方药市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球胃肠道OTC药物市场的影响是什么？
  • 主要的区域市场是什么？
  • 哪些国家代表了最具吸引力的胃肠道非处方药市场？
  • 基于药物类别的市场细分是什么？
  • 胃肠道非处方药市场中最有吸引力的药物类别是什么？
  • 基于适应症的市场细分情况是怎样的？
  • 胃肠道OTC药物市场中最有吸引力的适应症是什么？
  • 基于终端用户的市场细分是什么？
  • 在胃肠道非处方药市场中，哪一个是最有吸引力的终端用户？
  • 全球胃肠道OTC药物市场的竞争结构是什么？
  • 谁是全球胃肠道OTC药物市场的主要参与者/公司？

目录

第一章：前言

第二章：范围和方法

  • 研究的目标
  • 利益相关者
  • 数据来源
    • 主要来源
    • 二级来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球胃肠道非处方药市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：按药物类别分類的市场

  • 泻药
    • 市场趋势
    • 市场预测
  • 胃肠道癌症治疗药物
    • 市场趋势
    • 市场预测
  • 胃酸减少剂
    • 市场趋势
    • 市场预测
  • 止泻药
    • 市场趋势
    • 市场预测
  • 质子泵抑制剂
    • 市场趋势
    • 市场预测
  • H2抑制剂
    • 市场趋势
    • 市场预测
  • 胃酸中和剂
    • 市场趋势
    • 市场预测
  • 肠道抗炎剂
    • 市场趋势
    • 市场预测
  • 抗化妆品
    • 市场趋势
    • 市场预测

第7章 ：按适应症分類的市场

  • 胃食管反流病（GERD）或烧心病
    • 市场趋势
    • 市场预测
  • 便秘
    • 市场趋势
    • 市场预测
  • 腹泻
    • 市场趋势
    • 市场预测
  • 晕动症
    • 市场趋势
    • 市场预测
  • 其他
    • 市场趋势
    • 市场预测

第8章：按终端用户分類的市场

  • 医院
    • 市场趋势
    • 市场预测
  • 诊所
    • 市场趋势
    • 市场预测
  • 其他
    • 市场趋势
    • 市场预测

第九章：按地区分類的市场

  • 北美洲
    • 美国
      • 市场趋势
      • 市场预测
    • 加拿大
      • 市场趋势
      • 市场预测
  • 亚太地区
    • 中国
      • 市场趋势
      • 市场预测
    • 日本
      • 市场趋势
      • 市场预测
    • 印度
      • 市场趋势
      • 市场预测
    • 韩国
      • 市场趋势
      • 市场预测
    • 澳大利亚
      • 市场趋势
      • 市场预测
    • 印尼
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 欧洲
    • 德国
      • 市场趋势
      • 市场预测
    • 法国
      • 市场趋势
      • 市场预测
    • 英国
      • 市场趋势
      • 市场预测
    • 意大利
      • 市场趋势
      • 市场预测
    • 西班牙
      • 市场趋势
      • 市场预测
    • 俄罗斯
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场趋势
      • 市场预测
    • 墨西哥
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 中东和非洲
    • 市场趋势
    • 按国家分類的市场
    • 市场预测

第十章：驱动因素、限制因素和机会

  • 概述
  • 驱动因素
  • 限制因素
  • 机会

第十一章 ：价值链分析

第十二章 ：波特斯五力分析

  • 概述
  • 买方的讨价还价能力
  • 供应商的讨价还价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十三章 ：价格分析

第十四章：竞争格局

  • 市场结构
  • 主要参与者
  • 主要参与者的简介
    • Boehringer Ingelheim GmbH
    • Johnson & Johnson
    • Prestige Consumer Healthcare Inc.
    • Purdue Pharma L.P
    • Sanofi
    • Zydus Lifesciences Limited

请注意，这只代表部分公司的名单，完整的名单已在报告中提供。

Product Code: SR112023A7781

The global gastrointestinal OTC drugs market size reached US$ 40 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 52.4 Billion by 2028, exhibiting a growth rate (CAGR) of 4.90% during 2023-2028. The rising prevalence of gastrointestinal disorders, increasing awareness among the masses regarding digestive health, and the recent development of advanced formulations represent some of the key factors driving the market.

Gastrointestinal over-the-counter (OTC) drugs refer to non-prescription medications that alleviate gastrointestinal symptoms and promote overall digestive wellness. It includes laxatives, antacids, H2 blockers, proton pump inhibitors (PPIs), anti-emetics, bowel anti-inflammatory, and anti-diarrheal medications. Gastrointestinal OTC drugs are widely used to treat indigestion, constipation, heartburn, diarrhea, motion sickness, acid reflux, nausea, irritable bowel syndrome (IBS), and abdominal pain. It is a cost-effective, convenient, and easily accessible product that provides immediate relief, enhances patient comfort, and allows self-management. Gastrointestinal OTC drugs also aid in improving gut health, restoring beneficial bacteria, preventing future complications, and minimizing the severity of various symptoms, such as pain, bloating, abdominal discomfort, and vomiting.

Gastrointestinal OTC Drugs Market Trends:

The rising prevalence of gastrointestinal disorders due to sedentary lifestyles and unhealthy eating habits is one of the key factors providing a thrust to the market growth. Gastrointestinal OTC drugs are widely used to treat infections, dyspepsia, acute diarrhea, heartburn, gastroesophageal reflux disease (GERD), constipation, bloating, and morning sickness. Furthermore, the increasing product applications to improve digestion, promote gut health, and ensure proper breakdown and absorption of nutrients, owing to the growing awareness among the masses regarding digestive health, is providing an impetus to the market growth. In line with this, the emerging trends of self-care and consumer empowerment to manage well-being and prevent future health complications are acting as another growth-inducing factor. Additionally, the recent development of advanced formulations, such as effervescent tablets, liquids, suspensions, film strips, and chewable products, which enhances the effectiveness of the drugs, increases absorption, and reduces the frequency of dosing, is positively influencing the market growth. Besides this, the introduction of convenient and travel-friendly packaging, such as blister packs, resealable pouches, and single-dose packets, is propelling the market growth. Apart from this, the rising consumer preference for non-invasive treatments is facilitating product demand to manage common digestive issues and provide immediate relief. Moreover, aggressive promotional and branding campaigns by several manufacturers through television (TV) commercials, social media, influencer marketing, and celebrity endorsement is strengthening the market growth. Other factors, including the rising geriatric populations, increasing expenditure capacities of consumers, and easy availability of products across e-commerce platforms, are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global gastrointestinal OTC drugs market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on drug class, indication, and end user.

Drug Class Insights:

Laxatives

Gastrointestinal Cancer Treatments

Gastric Acid Reducers

Anti-Diarrheal

Proton Pump Inhibitors

H2 Inhibitors

Gastric Acid Neutralizers

Bowel Anti-Inflammatory

Anti-Emetics

The report has provided a detailed breakup and analysis of the gastrointestinal OTC drugs market based on the drug class. This includes laxatives, gastrointestinal cancer treatments, gastric acid reducers, anti-diarrheal, proton pump inhibitors, H2 inhibitors, gastric acid neutralizers, bowel anti-inflammatory, and anti-emetics.

Indication Insights:

Gastroesophageal Reflux Disease (GERD) or Heartburn

Constipation

Diarrhea

Motion Sickness

Others

A detailed breakup and analysis of the gastrointestinal OTC drugs market based on the indication has also been provided in the report. This includes gastroesophageal reflux disease (GERD) or heartburn, constipation, diarrhea, motion sickness, and others.

End User Insights:

Hospitals

Clinics

Others

A detailed breakup and analysis of the gastrointestinal OTC drugs market based on the end user has also been provided in the report. This includes hospitals, clinics, and others.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for gastrointestinal OTC drugs. Some of the factors driving the North America gastrointestinal OTC drugs market included the rising prevalence of gastrointestinal disorders, increasing awareness among the masses, and various product innovations.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global gastrointestinal OTC drugs market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Boehringer Ingelheim GmbH, Johnson & Johnson, Prestige Consumer Healthcare Inc., Purdue Pharma L.P, Sanofi, Zydus Lifesciences Limited, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global gastrointestinal OTC drugs market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global gastrointestinal OTC drugs market?
  • What is the impact of each driver, restraint, and opportunity on the global gastrointestinal OTC drugs market?
  • What are the key regional markets?
  • Which countries represent the most attractive gastrointestinal OTC drugs market?
  • What is the breakup of the market based on the drug class?
  • Which is the most attractive drug class in the gastrointestinal OTC drugs market?
  • What is the breakup of the market based on the indication?
  • Which is the most attractive indication in the gastrointestinal OTC drugs market?
  • What is the breakup of the market based on end user?
  • Which is the most attractive end user in the gastrointestinal OTC drugs market?
  • What is the competitive structure of the global gastrointestinal OTC drugs market?
  • Who are the key players/companies in the global gastrointestinal OTC drugs market?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global Gastrointestinal OTC Drugs Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Drug Class

  • 6.1  Laxatives
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2  Gastrointestinal Cancer Treatments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3  Gastric Acid Reducers
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4  Anti-Diarrheal
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5  Proton Pump Inhibitors
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6  H2 Inhibitors
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7  Gastric Acid Neutralizers
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8  Bowel Anti-Inflammatory
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast
  • 6.9  Anti-Emetics
    • 6.9.1 Market Trends
    • 6.9.2 Market Forecast

7   Market Breakup by Indication

  • 7.1  Gastroesophageal Reflux Disease (GERD) or Heartburn
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Constipation
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3  Diarrhea
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4  Motion Sickness
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5  Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8   Market Breakup by End User

  • 8.1  Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3  Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9   Market Breakup by Region

  • 9.1  North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2  Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3  Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4  Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5  Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10  Drivers, Restraints, and Opportunities

  • 10.1  Overview
  • 10.2  Drivers
  • 10.3  Restraints
  • 10.4  Opportunities

11  Value Chain Analysis

12  Porters Five Forces Analysis

  • 12.1  Overview
  • 12.2  Bargaining Power of Buyers
  • 12.3  Bargaining Power of Suppliers
  • 12.4  Degree of Competition
  • 12.5  Threat of New Entrants
  • 12.6  Threat of Substitutes

13  Price Analysis

14  Competitive Landscape

  • 14.1  Market Structure
  • 14.2  Key Players
  • 14.3  Profiles of Key Players
    • 14.3.1  Boehringer Ingelheim GmbH
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 SWOT Analysis
    • 14.3.2  Johnson & Johnson
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3  Prestige Consumer Healthcare Inc. 
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4  Purdue Pharma L.P
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5  Sanofi
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6  Zydus Lifesciences Limited
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Gastrointestinal OTC Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Gastrointestinal OTC Drugs Market: Breakup by Drug Class (in %), 2022
  • Figure 5: Global: Gastrointestinal OTC Drugs Market: Breakup by Indication (in %), 2022
  • Figure 6: Global: Gastrointestinal OTC Drugs Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Gastrointestinal OTC Drugs Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Gastrointestinal OTC Drugs (Laxatives) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Gastrointestinal OTC Drugs (Laxatives) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Gastrointestinal OTC Drugs (Gastrointestinal Cancer Treatments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Gastrointestinal OTC Drugs (Gastrointestinal Cancer Treatments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Gastrointestinal OTC Drugs (Gastric Acid Reducers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Gastrointestinal OTC Drugs (Gastric Acid Reducers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Gastrointestinal OTC Drugs (Anti-Diarrheal) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Gastrointestinal OTC Drugs (Anti-Diarrheal) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Gastrointestinal OTC Drugs (Proton Pump Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Gastrointestinal OTC Drugs (Proton Pump Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Gastrointestinal OTC Drugs (H2 Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Gastrointestinal OTC Drugs (H2 Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Gastrointestinal OTC Drugs (Gastric Acid Neutralizers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Gastrointestinal OTC Drugs (Gastric Acid Neutralizers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Gastrointestinal OTC Drugs (Bowel Anti-Inflammatory) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Gastrointestinal OTC Drugs (Bowel Anti-Inflammatory) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Gastrointestinal OTC Drugs (Gastroesophageal Reflux Disease (GERD) or Heartburn) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Gastrointestinal OTC Drugs (Gastroesophageal Reflux Disease (GERD) or Heartburn) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Gastrointestinal OTC Drugs (Constipation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Gastrointestinal OTC Drugs (Constipation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Gastrointestinal OTC Drugs (Diarrhea) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Gastrointestinal OTC Drugs (Diarrhea) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Gastrointestinal OTC Drugs (Motion Sickness) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Gastrointestinal OTC Drugs (Motion Sickness) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Gastrointestinal OTC Drugs (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Gastrointestinal OTC Drugs (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Gastrointestinal OTC Drugs (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Gastrointestinal OTC Drugs (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Global: Gastrointestinal OTC Drugs (Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Global: Gastrointestinal OTC Drugs (Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Global: Gastrointestinal OTC Drugs (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Global: Gastrointestinal OTC Drugs (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: North America: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: North America: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: United States: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: United States: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Canada: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Canada: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Asia-Pacific: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Asia-Pacific: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: China: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: China: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Japan: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Japan: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: India: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: India: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: South Korea: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: South Korea: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Australia: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Australia: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Indonesia: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Indonesia: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Others: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Others: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Europe: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Europe: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Germany: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Germany: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: France: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: France: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: United Kingdom: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: United Kingdom: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Italy: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Italy: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Spain: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Spain: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Russia: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Russia: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Others: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Others: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Latin America: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Latin America: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Brazil: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Brazil: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Mexico: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Mexico: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Others: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 85: Others: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Middle East and Africa: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 87: Middle East and Africa: Gastrointestinal OTC Drugs Market: Breakup by Country (in %), 2022
  • Figure 88: Middle East and Africa: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Global: Gastrointestinal OTC Drugs Industry: Drivers, Restraints, and Opportunities
  • Figure 90: Global: Gastrointestinal OTC Drugs Industry: Value Chain Analysis
  • Figure 91: Global: Gastrointestinal OTC Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Gastrointestinal OTC Drugs Market: Key Industry Highlights, 2022 & 2028
  • Table 2: Global: Gastrointestinal OTC Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2023-2028
  • Table 3: Global: Gastrointestinal OTC Drugs Market Forecast: Breakup by Indication (in Million US$), 2023-2028
  • Table 4: Global: Gastrointestinal OTC Drugs Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Gastrointestinal OTC Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Gastrointestinal OTC Drugs Market: Competitive Structure
  • Table 7: Global: Gastrointestinal OTC Drugs Market: Key Players